nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphemanil Methylsulfate—Diphenylpyraline—SLC6A3—bipolar disorder	0.0142	1	CrCbGaD
Diphemanil Methylsulfate—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00491	0.00498	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.0049	0.00497	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00489	0.00497	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00482	0.00488	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—TRPC3—bipolar disorder	0.0048	0.00487	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—bipolar disorder	0.00479	0.00485	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Regulation of Actin Cytoskeleton—PIK3C2A—bipolar disorder	0.00477	0.00484	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00448	0.00454	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—TACR1—bipolar disorder	0.00446	0.00453	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—CLOCK—bipolar disorder	0.00434	0.0044	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00431	0.00437	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00429	0.00435	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—TPH2—bipolar disorder	0.00423	0.00429	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00421	0.00427	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00419	0.00425	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.004	0.00406	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00399	0.00405	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Other—HTR2A—bipolar disorder	0.00389	0.00395	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.0038	0.00385	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00379	0.00384	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00365	0.0037	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—TAC1—bipolar disorder	0.00364	0.00369	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00358	0.00363	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00357	0.00362	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Regulation of insulin secretion—INS—bipolar disorder	0.00353	0.00359	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—SLC6A4—bipolar disorder	0.00338	0.00343	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—DRD1—bipolar disorder	0.00338	0.00343	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—DRD3—bipolar disorder	0.00327	0.00332	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00326	0.00331	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00325	0.0033	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD5—bipolar disorder	0.0032	0.00325	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.0032	0.00325	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD5—bipolar disorder	0.00319	0.00324	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00319	0.00324	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—DRD4—bipolar disorder	0.00318	0.00322	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00296	0.00301	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00296	0.00301	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—DRD2—bipolar disorder	0.00296	0.003	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00296	0.003	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00296	0.003	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00286	0.00291	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00286	0.0029	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Integration of energy metabolism—INS—bipolar disorder	0.00278	0.00282	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00277	0.00281	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00277	0.00281	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00276	0.0028	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00276	0.0028	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00268	0.00272	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—NTRK1—bipolar disorder	0.00268	0.00272	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00267	0.00271	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.0026	0.00264	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00259	0.00263	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—IMPA2—bipolar disorder	0.00247	0.00251	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00245	0.00249	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00245	0.00248	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00242	0.00246	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00242	0.00245	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00242	0.00245	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00241	0.00244	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00237	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00237	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00236	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00236	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—ADM—bipolar disorder	0.00232	0.00235	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—ADM—bipolar disorder	0.00231	0.00234	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.0023	0.00233	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00229	0.00232	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—TSHB—bipolar disorder	0.00226	0.00229	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—TACR1—bipolar disorder	0.00226	0.00229	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—TSHB—bipolar disorder	0.00225	0.00228	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—TACR1—bipolar disorder	0.00225	0.00228	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00223	0.00226	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00222	0.00225	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.0022	0.00223	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00219	0.00222	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00208	0.00211	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00207	0.0021	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DGKH—bipolar disorder	0.00198	0.00201	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DGKH—bipolar disorder	0.00197	0.002	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00196	0.00199	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00196	0.00199	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—HTR1A—bipolar disorder	0.00187	0.0019	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—HTR1A—bipolar disorder	0.00186	0.00189	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—TAC1—bipolar disorder	0.00184	0.00187	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—TAC1—bipolar disorder	0.00183	0.00186	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD5—bipolar disorder	0.00181	0.00184	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD5—bipolar disorder	0.00181	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD1—bipolar disorder	0.0018	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—HTR2C—bipolar disorder	0.0018	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—HTR2C—bipolar disorder	0.0018	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD1—bipolar disorder	0.0018	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DGKH—bipolar disorder	0.0018	0.00182	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DGKH—bipolar disorder	0.00179	0.00182	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—RGS4—bipolar disorder	0.00178	0.0018	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—RGS4—bipolar disorder	0.00177	0.0018	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD3—bipolar disorder	0.00175	0.00177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD3—bipolar disorder	0.00174	0.00177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.0017	0.00172	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD4—bipolar disorder	0.0017	0.00172	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00169	0.00172	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD4—bipolar disorder	0.00169	0.00172	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—IMPA1—bipolar disorder	0.00167	0.00169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—GSK3B—bipolar disorder	0.00167	0.00169	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD5—bipolar disorder	0.00164	0.00167	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD5—bipolar disorder	0.00164	0.00166	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—RGS4—bipolar disorder	0.00161	0.00164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—RGS4—bipolar disorder	0.00161	0.00163	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD2—bipolar disorder	0.00158	0.0016	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD2—bipolar disorder	0.00158	0.0016	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00145	0.00147	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00145	0.00147	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NDUFV2—bipolar disorder	0.00142	0.00144	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AKR1C4—bipolar disorder	0.00138	0.0014	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00137	0.00139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—TRPC3—bipolar disorder	0.00137	0.00139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADM—bipolar disorder	0.00131	0.00133	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADM—bipolar disorder	0.00131	0.00132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—TSHB—bipolar disorder	0.00128	0.00129	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00128	0.00129	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—TACR1—bipolar disorder	0.00128	0.00129	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—TSHB—bipolar disorder	0.00127	0.00129	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PDE4B—bipolar disorder	0.00127	0.00129	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—TACR1—bipolar disorder	0.00127	0.00129	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—TRPC3—bipolar disorder	0.00125	0.00126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—TRPC3—bipolar disorder	0.00124	0.00126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NR1D1—bipolar disorder	0.00124	0.00125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADM—bipolar disorder	0.00119	0.00121	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADM—bipolar disorder	0.00119	0.0012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NCAN—bipolar disorder	0.00118	0.0012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00116	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—TSHB—bipolar disorder	0.00116	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PDE4B—bipolar disorder	0.00116	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—TACR1—bipolar disorder	0.00116	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SLC5A3—bipolar disorder	0.00116	0.00117	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00116	0.00117	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PDE4B—bipolar disorder	0.00115	0.00117	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—TSHB—bipolar disorder	0.00115	0.00117	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—TACR1—bipolar disorder	0.00115	0.00117	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKR1C4—bipolar disorder	0.00115	0.00117	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKR1C4—bipolar disorder	0.00115	0.00117	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	0.00111	0.00112	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—HTR2A—bipolar disorder	0.0011	0.00112	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DGKH—bipolar disorder	0.00106	0.00108	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DGKH—bipolar disorder	0.00106	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00106	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR1A—bipolar disorder	0.00105	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	0.00104	0.00106	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—TAC1—bipolar disorder	0.00104	0.00105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	0.00102	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00102	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR2C—bipolar disorder	0.00102	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD1—bipolar disorder	0.00102	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	0.000988	0.001	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD3—bipolar disorder	0.000985	0.000999	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD5—bipolar disorder	0.000971	0.000985	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD5—bipolar disorder	0.000968	0.000982	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	0.000959	0.000973	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	0.000959	0.000973	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR1A—bipolar disorder	0.000956	0.00097	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD4—bipolar disorder	0.000956	0.00097	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RGS4—bipolar disorder	0.000953	0.000966	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RGS4—bipolar disorder	0.00095	0.000963	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	0.000945	0.000958	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—TAC1—bipolar disorder	0.000942	0.000955	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	0.000926	0.00094	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	0.000926	0.00094	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR2C—bipolar disorder	0.000923	0.000937	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD1—bipolar disorder	0.000923	0.000937	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000903	0.000916	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADCY2—bipolar disorder	0.0009	0.000913	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	0.000897	0.00091	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD3—bipolar disorder	0.000894	0.000907	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	0.000893	0.000906	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD2—bipolar disorder	0.000891	0.000903	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—POMC—bipolar disorder	0.000884	0.000897	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—POMC—bipolar disorder	0.000881	0.000894	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	0.000871	0.000883	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD4—bipolar disorder	0.000868	0.000881	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CLOCK—bipolar disorder	0.000837	0.000849	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	0.00082	0.000832	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADCY2—bipolar disorder	0.000817	0.000829	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—TSHB—bipolar disorder	0.000816	0.000828	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—TPH2—bipolar disorder	0.000816	0.000828	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CACNB2—bipolar disorder	0.000816	0.000828	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	0.000811	0.000823	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD2—bipolar disorder	0.000809	0.00082	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—DPYD—bipolar disorder	0.000803	0.000814	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CACNA1C—bipolar disorder	0.000746	0.000757	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	0.000736	0.000747	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TRPC3—bipolar disorder	0.000734	0.000744	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PIK3C2A—bipolar disorder	0.000727	0.000738	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADM—bipolar disorder	0.000702	0.000712	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADM—bipolar disorder	0.0007	0.00071	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	0.000684	0.000694	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TSHB—bipolar disorder	0.000684	0.000694	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TACR1—bipolar disorder	0.000684	0.000694	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TSHB—bipolar disorder	0.000682	0.000692	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PDE4B—bipolar disorder	0.000682	0.000692	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TACR1—bipolar disorder	0.000682	0.000692	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SNAP25—bipolar disorder	0.000652	0.000662	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000626	0.000635	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR2A—bipolar disorder	0.000624	0.000633	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ADCY2—bipolar disorder	0.000577	0.000586	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	0.000568	0.000576	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	0.000567	0.000575	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR2A—bipolar disorder	0.000566	0.000575	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR1A—bipolar disorder	0.000565	0.000573	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TAC1—bipolar disorder	0.000558	0.000566	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TAC1—bipolar disorder	0.000556	0.000564	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	0.000547	0.000555	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD1—bipolar disorder	0.000547	0.000555	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD1—bipolar disorder	0.000545	0.000553	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR2C—bipolar disorder	0.000545	0.000553	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	0.000532	0.00054	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	0.000531	0.000538	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD3—bipolar disorder	0.00053	0.000538	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD3—bipolar disorder	0.000528	0.000536	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	0.000528	0.000535	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	0.000526	0.000534	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD4—bipolar disorder	0.000514	0.000522	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD4—bipolar disorder	0.000513	0.00052	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	0.0005	0.000507	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	0.000498	0.000505	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—COMT—bipolar disorder	0.000494	0.000501	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MAOA—bipolar disorder	0.000491	0.000498	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	0.000484	0.000491	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	0.000483	0.00049	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	0.000483	0.00049	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	0.000481	0.000488	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD2—bipolar disorder	0.000479	0.000486	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD2—bipolar disorder	0.000478	0.000485	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—POMC—bipolar disorder	0.000454	0.00046	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—POMC—bipolar disorder	0.000452	0.000459	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	0.000434	0.00044	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	0.000433	0.000439	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—S100B—bipolar disorder	0.000422	0.000428	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—S100B—bipolar disorder	0.00042	0.000427	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MTHFR—bipolar disorder	0.0004	0.000405	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NRG1—bipolar disorder	0.000372	0.000378	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NRG1—bipolar disorder	0.000371	0.000376	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	0.000336	0.00034	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	0.000335	0.000339	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—POMC—bipolar disorder	0.00032	0.000324	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—INS—bipolar disorder	0.000318	0.000322	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	0.00027	0.000274	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	0.000269	0.000273	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—POMC—bipolar disorder	0.000268	0.000272	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—POMC—bipolar disorder	0.000267	0.000271	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INS—bipolar disorder	0.000267	0.00027	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INS—bipolar disorder	0.000266	0.00027	CbGpPWpGaD
